SHPH Total Utang marang Modal Shuttle Pharma

SHPH (Shuttle Pharmaceuticals Holdings) - tandha merek perusahaan

The historical debt-to-equity chart for Shuttle Pharmaceuticals (SHPH) is 0.01. The company's operations focus on developing agents in US laboratories that increase the radiosensitivity of head and neck neoplasms. Scaling prospects depend on integrating patented methods into global oncology practice, while the current stage is characterized by the expenditure of available funds on intensive scientific research.

Rasio Utang marang Ekuitas: shuttlepharma.com (SHPH) kanggo 28.04.2023 - 28.10.2026

Rincian metrik komprehensif lan analitis Shuttle Pharmaceuticals Inc (SHPH)

- rega lan prakiraan konsensus rega:
Rega saham Shuttle Pharmaceuticals Holdings|SHPH - Target konsensus
- data kapitalisasi pasar:
Kapitalisasi pasar Shuttle Pharmaceuticals|SHPH - Nilai Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Siji Saham Shuttle Pharmaceuticals|SHPH - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku shuttlepharma.com|SHPH - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Shuttle Pharmaceuticals|SHPH - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Shuttle Pharmaceuticals|SHPH - Kewajiban utang agregat|Utang marang nilai buku Shuttle Pharmaceuticals|SHPH - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Shuttle Pharmaceuticals
Analisis komprehensif perusahaan:SHPH - Shuttle Pharmaceuticals Holdings
Sampel barang Shuttle Pharmaceuticals

This ratio determines the degree of financial leverage by comparing total liabilities to net assets to assess insolvency risks and capital structure efficiency. By analyzing the dynamics of equity dependence on debt via GURU.Markets, an investor can observe the balance of borrowed funds, which is critically important for Shuttle Pharmaceuticals (SHPH) during the development of innovative sensitizers for oncology.

Pesaing utama

Total Utang marang Modal CNSP